Skip to content

C1 Inhibitor Deficiency C1852700

Published: July 22, 2026Updated: August 20, 2026

A genetic disorder causing recurrent episodes of severe swelling in various body parts. Can be life-threatening if swelling affects the airway. Managed with preventive and acute treatments.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D89.9
ICD-11
3A00.0
Body system
immunologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Airway obstruction due to laryngeal edema

Generalized symptoms

(immunologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Recurrent angioedema episodes

(Immunologic)

Abdominal pain due to intestinal edema

(Gastrointestinal)

Erythema marginatum

(Dermatologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

C1-inhibitor replacement therapy

Intravenous replacement of deficient C1-inhibitor protein to restore normal function and prevent angioedema attacks. This addresses the underlying deficiency directly.

medication
2

Targeted drug therapy with dose adjustment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Bradykinin receptor antagonist

Selective bradykinin B2 receptor antagonist administered subcutaneously to block the cascade leading to swelling during acute episodes.

medication

Additional treatment options

Antifibrinolytic agents

Oral agents that inhibit plasmin and may reduce frequency of attacks as preventive therapy for some patients.

medication

Trigger avoidance and attack prevention

Identification and avoidance of known triggers such as ACE inhibitors, estrogen-containing contraceptives, and physical trauma. Patient education on early symptom recognition.

lifestyle

Regular disease monitoring and attack documentation

Ongoing assessment of attack frequency, severity, and response to treatment with regular follow-up to optimize prophylactic therapy.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is C1 Inhibitor Deficiency C1852700?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Craig TJ, Bernstein JA, Li HH, et al. International consensus on the diagnosis and management of hereditary angioedema with C1-inhibitor deficiency. Ann Allergy Asthma Immunol. 2022;128(5):505-514.

guideline2022View source →
2

Zuraw BL, Christiansen SC. Hereditary angioedema: the clinical spectrum of bradykinin-mediated angioedema. Immunol Allergy Clin North Am. 2023;43(2):229-245.

review2023View source →
3

Riedl MA, Lumry WR, Benschop R, et al. Safety and efficacy of subcutaneous C1-esterase inhibitor for hereditary angioedema: results of the COMPACT trial extension. J Allergy Clin Immunol Pract. 2021;9(7):2732-2741.

clinical_trial2021View source →
4

Mansi M, Zanichelli A, Cozzani E, et al. Modern therapies for hereditary angioedema: a systematic review of efficacy and safety. Clin Rev Allergy Immunol. 2020;59(3):336-352.

meta_analysis2020View source →

Medication Comparisons

Compare medications used to treat C1 Inhibitor Deficiency C1852700. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy